These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24582537)

  • 1. Autologous muscle derived cells for treatment of stress urinary incontinence in women.
    Peters KM; Dmochowski RR; Carr LK; Robert M; Kaufman MR; Sirls LT; Herschorn S; Birch C; Kultgen PL; Chancellor MB
    J Urol; 2014 Aug; 192(2):469-76. PubMed ID: 24582537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous muscle derived cell therapy for stress urinary incontinence: a prospective, dose ranging study.
    Carr LK; Robert M; Kultgen PL; Herschorn S; Birch C; Murphy M; Chancellor MB
    J Urol; 2013 Feb; 189(2):595-601. PubMed ID: 23260547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, randomized, placebo-controlled clinical trial evaluating the safety and efficacy of autologous muscle derived cells in female subjects with stress urinary incontinence.
    Jankowski RJ; Tu LM; Carlson C; Robert M; Carlson K; Quinlan D; Eisenhardt A; Chen M; Snyder S; Pruchnic R; Chancellor M; Dmochowski R; Kaufman MR; Carr L
    Int Urol Nephrol; 2018 Dec; 50(12):2153-2165. PubMed ID: 30324580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraurethral injection of autologous minced skeletal muscle: a simple surgical treatment for stress urinary incontinence.
    Gräs S; Klarskov N; Lose G
    J Urol; 2014 Sep; 192(3):850-5. PubMed ID: 24735937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary application of autologous muscle-derived cells for urinary sphincter regeneration.
    Kaufman MR
    World J Urol; 2020 Sep; 38(9):2095-2099. PubMed ID: 31834471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prospective evaluation of intrasphincteric injections of autologous muscular cells in patients with stress urinary incontinence following radical prostatectomy].
    Cornu JN; Doucet C; Sèbe P; Ciofu C; Gil Diez de Medina S; Vallancien G; Amarenco G; Cussenot O; Pinset C; Haab F
    Prog Urol; 2011 Nov; 21(12):859-65. PubMed ID: 22035912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of autologous muscle-derived cells in the treatment of urinary incontinence in female patients with intrinsic sphincter deficiency and epispadias: A prospective study.
    Sharifiaghdas F; Tajalli F; Taheri M; Naji M; Moghadasali R; Aghdami N; Baharvand H; Azimian V; Jaroughi N
    Int J Urol; 2016 Jul; 23(7):581-6. PubMed ID: 27062371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do pad tests and voiding diaries affect patient willingness to participate in studies of incontinence treatment outcomes?
    Singh M; Bushman W; Clemens JQ
    J Urol; 2004 Jan; 171(1):316-8; discussion 318-9. PubMed ID: 14665904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regenerative treatment of male stress urinary incontinence by periurethral injection of autologous adipose-derived regenerative cells: 1-year outcomes in 11 patients.
    Gotoh M; Yamamoto T; Kato M; Majima T; Toriyama K; Kamei Y; Matsukawa Y; Hirakawa A; Funahashi Y
    Int J Urol; 2014 Mar; 21(3):294-300. PubMed ID: 24033774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous Muscle-derived Cell Injection for Treatment of Female Stress Urinary Incontinence: A Single- Arm Clinical Trial with 24-months Follow-Up.
    Sharifiaghdas F; Zohrabi F; Moghadasali R; Shekarchian S; Jaroughi N; Bolurieh T; Baharvand H; Aghdami N
    Urol J; 2019 Oct; 16(5):482-487. PubMed ID: 31004339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term structural and functional effects of autologous muscle precursor cell therapy in a nonhuman primate model of urinary sphincter deficiency.
    Badra S; Andersson KE; Dean A; Mourad S; Williams JK
    J Urol; 2013 Nov; 190(5):1938-45. PubMed ID: 23618586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsurgical transurethral collagen denaturation for stress urinary incontinence in women: 12-month results from a prospective long-term study.
    Elser DM; Mitchell GK; Miklos JR; Nickell KG; Cline K; Winkler H; Wells WG
    J Minim Invasive Gynecol; 2009; 16(1):56-62. PubMed ID: 19013110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periurethral skeletal myofibre implantation in patients with urinary incontinence and intrinsic sphincter deficiency: a phase I clinical trial.
    Yiou R; Hogrel JY; Loche CM; Authier FJ; Lecorvoisier P; Jouany P; Roudot-Thoraval F; Lefaucheur JP
    BJU Int; 2013 Jun; 111(7):1105-16. PubMed ID: 23470219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tension-free vaginal tape and autologous rectus fascia pubovaginal sling for the treatment of urinary stress incontinence: a medium-term follow-up.
    Sharifiaghdas F; Mortazavi N
    Med Princ Pract; 2008; 17(3):209-14. PubMed ID: 18408389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial experience and results with a new adjustable transobturator male system for the treatment of stress urinary incontinence.
    Seweryn J; Bauer W; Ponholzer A; Schramek P
    J Urol; 2012 Mar; 187(3):956-61. PubMed ID: 22264469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective analysis of 373 consecutive women with stress urinary incontinence treated with a vaginal wall sling: the Columbia-Cornell University experience.
    Kaplan SA; Te AE; Young GP; Andrade A; Cabelin MA; Ikeguchi EF
    J Urol; 2000 Nov; 164(5):1623-7. PubMed ID: 11025719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationships among measures of incontinence severity in women undergoing surgery for stress urinary incontinence.
    Albo M; Wruck L; Baker J; Brubaker L; Chai T; Dandreo KJ; Diokno A; Goode P; Kraus S; Kusek JW; Lemack G; Lowder J; Steers W;
    J Urol; 2007 May; 177(5):1810-4. PubMed ID: 17437826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety and efficacy of a new adjustable single incision sling for female stress urinary incontinence.
    Kocjancic E; Tu LM; Erickson T; Gheiler E; Van Drie D
    J Urol; 2014 Nov; 192(5):1477-82. PubMed ID: 24907444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous myoblasts and fibroblasts versus collagen for treatment of stress urinary incontinence in women: a randomised controlled trial.
    Strasser H; Marksteiner R; Margreiter E; Pinggera GM; Mitterberger M; Frauscher F; Ulmer H; Fussenegger M; Kofler K; Bartsch G
    Lancet; 2007 Jun; 369(9580):2179-2186. PubMed ID: 17604800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant Transurethral and Transvaginal-Periurethral Injection of Autologous Adipose Derived Stem Cells for Treatment of Female Stress Urinary Incontinence: A Phase One Clinical Trial.
    Arjmand B; Safavi M; Heidari R; Aghayan H; T Bazargani S; Dehghani S; Goodarzi P; Mohammadi-Jahani F; Heidari F; Payab M; Pourmand G
    Acta Med Iran; 2017 Jun; 55(6):368-374. PubMed ID: 28843237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.